PART II AND III

An Offering statement pursuant to Regulation A relating to these securities
has been filed with the Securities and Exchange Commission ("SEC").
Information contained in this Offering Circular is subject to completion or
amendment. These securities may not be sold nor may offers to buy be accepted
before the Offering statement filed with the SEC is qualified. This
Preliminary Offering Circular shall not constitute an offer to sell or the
solicitation of an offer to buy nor may there be any sales of these
securities in any state in which such offer, solicitation or sale would be
unlawful before registration or qualification under the laws of any such
state. We have listed the links to our SEC filings on our website,
decontaminate.ai
Decontaminate, Inc.
Minimum Offering of 5,000,000 shares of common stock
Maximum Offering of 20,000,000 shares of common stock

Decontaminate Inc (The Company), A Delaware corporation hereby offers
investment shares in a Combination Nano-Technology Artificial Intelligence
company that has four components to its business:

A) Pathogen Detection (Covid-19, Influenza, MRSA to name a few) on surfaces
and in the air using Sensors, Cantilevers, Drones, Robots and Artificial
Intelligence
B) Decontamination of Pathogens, Molds and Microbes using Biosurfactants
C) Applying a Biofilm to deter pathogen formation
D) Janitorial Services using Robots and Drones for basic Cleaning Services

   This is an initial public offering of our shares of common
stock. We are offering up to a maximum of 20,000,000 shares of
common stock at an offering price of $1.00 per share with a
minimum offering amount of $5,000,000 (the ?Minimum Offering
Amount?) and a maximum offering amount of $20,000,000 (the
?Maximum Offering Amount?) (collectively, the ?Offering?). The
Offering will terminate on the earliest of: (1) the date on
which the Maximum Offering Amount has been sold, (2) the date
which is one year after this Offering being qualified by the
U.S. Securities and Exchange Commission (the ?SEC?), or (3) the
date on which this Offering is earlier terminated by us in our
sole discretion and for any reason (the ?Termination Date?).

The shares offered hereby are highly speculative and an
investment in the shares involves a high degree of risk.
Investors must be prepared to bear the economic risk of the
investment for an indefinite period and be able to withstand a
total loss of their investment.

Offering Circular dated September 15, 2020

Until we achieve the Minimum Offering Amount, the proceeds for
the Offering will be kept in a non-interest-bearing account (the
?Offering Escrow Account?). Upon achievement of not less than
the Minimum Offering Amount and the closing on such amount, the
proceeds will be distributed to us in one closing and the
associated shares will be issued to the investors. If the
Offering does not achieve the Minimum Offering Amount, and
therefore does not close, the proceeds for the Offering will be
promptly returned to investors, without deduction and without
interest. We will obtain Escrow Account agent after the Offering
has been qualified by the SEC.


   Price per share to the public is $1.00 underwriting
commissions are 0 at this time.
   Total Minimum is $5,000,000 or 5,000,000 common stock shares
   Total Maximum is $20,000,000 or 20,000,000 common stock shares
The expenses of this offering are expected to be between $60,000
and $275,000.




   This Offering is being conducted on a ?best efforts? basis
pursuant to Regulation A of Section 3(6) of the Securities Act
of 1933, as amended (the ?Securities Act?), for Tier 1
Offerings. We intend to complete one closing. Until we complete
the closing, the proceeds for this Offering will be kept in an
offering deposit account maintained by an Escrow agent named
later. The minimum purchase requirement per investor is 1,000
shares of Common Stock $1,000; however, we can waive the minimum
purchase requirement on a case-by-case basis in our sole
discretion.

   We expect to commence the sale of the shares as of the date on
which the Offering Statement of which this Offering Circular is
a part is declared qualified by the SEC.
   We are an ?emerging growth company? as defined in the
Jumpstart Our Business Startups Act, or the JOBS Act, and, as
such, may elect to comply with certain reduced reporting
requirements for this Offering Circular and future filings after
this Offering.
   Investing in our common stock involves a high degree of risk.
Please see ?Risk Factors? in this offering circular, for a
listing of certain risks that you should consider before
investment in our common stock.
   Generally, no sale may be made to you in this Offering if the
aggregate purchase price you pay is more than ten percent (10%)
of the greater of your annual income or your net worth.
Different rules apply to accredited investors and non-natural
persons. Before making any representation that your investment
does not exceed applicable thresholds, we encourage you to
review Rule 251(d)(2)(i)(c) of Regulation a+. For general
information on investing, we encourage you to refer to
www.investor.gov.
   The SEC does not pass upon the merits of or give its approval
to any securities offered or the terms of the Offering, nor does
it pass upon the accuracy or completeness of any Offering
Circular or other solicitation materials. These securities are
offered pursuant to an exemption from registration with the SEC;
however, the SEC has not made an independent determination that
the securities offered are exempt from registration.
   This Offering Circular follows the disclosure format of Part I
pursuant to the general instructions of Part II(a)(1)(ii) of
Form 1-A.

Initially, we will not enlist the assistance of anyone or any
entity to help us with the placement of this offering. If we do
decide to use federally registered Broker Dealer ?SEC?, we will
amend our offering with the SEC.

This offering circular contains the narrative section of the
Form 1-A Offering Circular and requires us to provide
disclosures about our business, officer and director
biographical information, material risks of the offering, uses
of offering proceeds, management?s discussion and analysis,
officer and director compensation, beneficial ownership
information, related party transaction, and the security being
offered.
The price of the common stock offered to the public is
considered by the company to be fair and reasonable.

230.251 Scope of SEC exemption.
(a) Tier 1 and Tier 2. A public offer or sale of eligible
securities, as defined in Rule 261 (230.261), pursuant to
Regulation A shall be exempt under section 3(b) from the
registration requirements of the Securities Act of 1933 (the
?Securities Act?) (15 U.S.C. 77a et seq.).
(1) Tier 1. Offerings pursuant to Regulation A in which the sum
of all cash and other consideration to be received for the
securities being offered (?aggregate offering price?) plus the
gross proceeds for all securities sold pursuant to other
offering statements within the 12 months before the start of
and during the current offering of securities (?aggregate
sales?) does not exceed $20,000,000, including not more than
$6,000,000 offered by all selling securityholders that
are affiliates of the  issuer (?Tier 1 offerings?).



The Company may engage a FINRA member to assist in the placement
of this offering.
See Plan of Distribution page 45 for details of compensation
paid to the
Broker if and when the Broker is chosen.

The Company may engage an escrow agent to hold funds tendered by
investors in
compliance with SEC Rules 15c2-4 and 10b-9.
The offering is being conducted on a best-efforts basis with a
minimum
offering amount of $1,000,000.
The offering will terminate at the earlier of dates.
The date at which the maximum
offering amount has been sold.
The date which is one year from this offering being
qualified by the Commission.
The date at which the offering is earlier terminated by the
company in our sole discretion.

Decontaminate Inc The Company, hereby offers investment
shares in a Combination Nano-Technology Artificial Intelligence
 company that has four components to the business

Pathogen Detection -Covid-19, Influenza,
MRSA to name a few- on surfaces
and in the air using Sensors, Cantilevers, Drones,
Robots and Artificial Intelligence
Decontamination of Pathogens, Molds and
Microbes using Biosurfactants
Applying a Biofilm to deter pathogen formation
Janitorial Services using Robots and Drones for
basic Cleaning Services


The shares offered hereby are highly speculative
and an investment in the
shares involves a high degree of risk.
Investors must be prepared to bear the economic risk
of the investment for an indefinite period and be able to
withstand a total loss of their investment.


I. Regulation A Filing

II. Regulatory Disclosures and Risk Factors


This Offering Circular has 2 parts

Summary of Information		Pages 10 through 18

Detailed Information		Page 18 through 55



Section 1	Summary Information


Summary of Company Information					Page 11
Artificial Intelligence, Cantilevers/Robots/Drone Scanning,
Virus and Disease Detection, Decontamination and Biofilm.
Focus on Covid-19 and Influenza

The Technology							Page 11
 Using Machine Learning Algorithms, Nanotechnology
 and Biosurfactants

4 Components of Business						Page 12
Detection, Decontaminate, Biofilms and Cleaning



Artificial Intelligence Patent Applications 				Page
13
Provisional and Non-Provisional

Domain Names							Page 14
List of Domain names

Rhamnolipid Biosurfactants						Page 14
Non-toxic pathogen cell piercing applications and Biofilms


6th Generation Drone							Page 15
Updated with sensors and associated algorithms

Regulatory Filings							Page 15
Environmental Protection Agency


Artificial Intelligence, Microbes and Clusters			Page
16
Predicting the future, specific data from the past

Marketing, Business Development and Free Scans			Page
16
Predicting the future, specific data from the past


Cleaning, Operations and Autonomous Vehicles			Page 18
Nuclear power, Hydrogen fuel cells and self-driving robots


Funding Requirements, Pre-Funding Value				Page 19
Assets and Valuations



Section 2.	Artificial Intelligence, Combination Nano-
Technologies


How our Service works						Page 19
Combination Nano-Technologies

High Definition Pictures						Page 20
Microbe facial recognition

Cantilevers								Page 20
What are they

Drones									Page 21
Present and Future

Robots									Page 21
Present and Future

Artificial Intelligence							Page 21

Can machines do what we do better


Algorithms and Deep Learning					Page 22
Neural Learning

Artificial Intelligence in the personal services business
	Page 21
Janitorial Services in the United States

Disrupting the workplace						Page 22
Present and Future

Covid-19, Influenza and what may be next 				Page
23
Disinfecting with rhamnolipid

Indoor Contamination and Air Pollution				Page 25
An environment can be contaminated without it being polluted

Sick Building Syndrome						Page 28
Using Machine Learning Algorithms and Nanotechnology
Cleaning an indoor environment with AI

AI Decontamination Biosurfactant Overview			Page 28
Disinfecting, Decontamination and Preventive Guideline Report.
COVID-19, the Flu and disease and virus detection.

Physical Application							Page 31
Sensors and electrostatic sprays

Superbugs, Viruses and Rhamnolipid					Page 31
Rhamnolipid is able to break apart the cells walls of pathogens

What causes Infectious Diseases					Page 32
Viruses, disease and their transfer

The spread of Pathogens and Viruses					Page
32
Airborne and surface attachment

Characterization of Rhamnolipids against Covid-19			Page
33
Third party periodical-Abstract

Section 3 the Janitorial Services Industry



Present Industrial Cleaning Business				Page 35
A necessity not a luxury

Present Janitorial Industry Costs					Page 35
Residential/ Commercial

Commercial Cleaning Rates						Page 35
2019

Flat Rates								Page 37
4 Scanning options

Commercial Cleaning Hourly Rates				Page 37
Research Data

Cleaning Chart link						Page 37
Disinfecting, Decontamination and Preventive Guideline Report.
COVID-19, the Flu and disease and virus detection.

How we offer our Services					Page 38
Type, Size and Severity of Contamination

Basic Pricing for our Services 				Page 39
Basic Scans, Residential Scans, Business Scans

Present Marketing						Page 40
Cold Calling, Flyers and Free Scans showcasing our Technology

How we offer our Services					Page 38
Type, Size and Severity of Contamination

Basic Pricing for our Services 				Page 39
Basic Scans, Residential Scans, Business Scans

Phase I Marketing						Page 40
Website Buildouts, Social Media, Interactive
Client Center

Use of Proceeds						Page 41
NanoTechnology Combination NT Combo

Risk Factors			Page 42
Industry Risks

Management			Page 44

Board of Directors		Page 44

Contact				Page 45



Exhibit A  Financials  and accompanying notes
?
I. Regulation A filing
The Company is in the process of filing a Regulation A
 Offering Circular with the Securities and Exchange Commission.
The CEO has registered with the SEC filing system called Edgar
to complete the necessary filings.
II. Regulatory Disclosures and Risk factors
THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION
DOES NOT PASS UPON THE MERITS OR GIVE ITS APPROVAL OF
ANY SECURITIES OFFERED OR THE TERMS OF THE OFFERING,
NOR DOES IT PASS UPON THE ACCURACY OR COMPLETENESS
OF ANY OFFERING CIRCULAR OR OTHER SOLICITATION MATERIALS.
 THESE SECURITIES ARE OFFERED PURSUANT TO AN EXEMPTION
 FROM REGISTRATION WITH THE COMMISSION; HOWEVER,
THE COMMISSION HAS NOT MADE AN INDEPENDENT DETERMINATION
THAT THE SECURITIES OFFERED ARE EXEMPT FROM REGISTRATION.
GENERALLY, NO SALE MAY BE MADE TO YOU IN THIS OFFERING IF THE
AGGREGATE PURCHASE PRICE YOU PAY IS MORE THAN 10 percent OF THE
GREATER OF YOUR ANNUAL INCOME OR NET WORTH. DIFFERENT RULES
 APPLY TO ACCREDITED INVESTORS AND NON-NATURAL PERSONS.
BEFORE MAKING ANY REPRESENTATION THAT YOUR INVESTMENT
DOES NOT EXCEED APPLICABLE THRESHOLDS, WE ENCOURAGE YOU
 TO REVIEW RULE 251 d 2 i C OF REGULATION A. FOR GENERAL
 INFORMATION ON INVESTING, WE ENCOURAGE YOU TO REFER TO
www.investor.gov

This offering is inherently risky. See Risk Factors on page 40.



IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON
THEIR OWN EXAMINATION OF THE COMPANY AND THE TERMS OF THE
 OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED.

THE COMPANY RESERVES THE RIGHT TO REJECT ANY PROSPECTIVE
INVESTMENT IN WHOLE OR IN PART, OR TO ALLOT TO ANY PROSPECTIVE
INVESTOR LESS THAN THE AMOUNT OF SHARES SUCH INVESTOR DESIRES
TO PURCHASE.

THE INFORMATION CONTAINED IN THIS OFFERING CIRCULAR HAS BEEN
OBTAINED FROM SOURCES BELIEVED BY THE COMPANY TO BE RELIABLE,
AND SUCH INFORMATION IS BELIEVED BY THE COMPANY TO BE ACCURATE
AND COMPLETE.  HOWEVER, NEITHER THE DELIVERY OF THIS OFFERING
CIRCULAR NOR ANY SALE OF THE SHARES DESCRIBED HEREIN SHALL,
UNDER ANY CIRCUMSTANCES, CREATE ANY IMPLICATION THAT THE
INFORMATION CONTAINED HEREIN IS TRUE AND ACCURATE AS OF ANY
TIME SUBSEQUENT TO THE DATE WHICH APPEARS ON THE COVER PAGE
OF THIS OFFERING CIRCULAR. THE ARTIFICIAL INTELLIGENCE MARKET IS
DEVELOPING AND THERE IS NOT MUCH DATA AVAILABLE AND SOME OF
THE DATA THAT IS PUBLIC IS NOT CREDIBLE.

INVESTORS SHOULD NOT CONSTRUE THE CONTENTS OF THIS OFFERING
CIRCULAR
OR ANY COMMUNICATION, WHETHER WRITTEN OR ORAL, FROM THE COMPANY
OR ITS EMPLOYEES OR AGENTS, AS PERSONAL, LEGAL, TAX, ACCOUNTING,
OR OTHER PROFESSIONAL ADVICE.  EACH INVESTOR SHOULD CONSULT HIS
OWN COUNSEL, ACCOUNTANTS AND OTHER PROFESSIONAL ADVISORS AS TO
LEGAL, TAX, ACCOUNTING, AND RELATED MATTERS CONCERNING THEIR
INVESTMENT IN THIS OFFERING,

THE OFFERING CONTAINED HEREIN CAN BE WITHDRAWN AT ANY TIME
BEFORE
 CLOSING AND IS SPECIFICALLY MADE SUBJECT TO THE CONDITIONS
DESCRIBED
 IN THIS OFFERING CIRCULAR.  THE COMPANY RESERVES THE RIGHT TO
REJECT
ANY SUBSCRIPTION IN WHOLE OR IN PART.

EXCEPT AS INDICATED HEREIN, NO PERSON HAS BEEN AUTHORIZED TO
GIVE
ANY INFORMATION OR MAKE ANY REPRESENTATION OTHER THAN THOSE
CONTAINED IN THIS OFFERING CIRCULAR IN CONNECTION WITH THE OFFER
CONTAINED HEREIN AND, IF GIVEN OR MADE, SUCH INFORMATION OR
REPRESENTATION MUST NOT BE RELIED UPON.  THE COMPANY WILL MAKE
AVAILABLE TO EACH INVESTOR AND THEIR PURCHASER REPRESENTATIVE
DURING THIS OFFERING AND PRIOR TO THE SALE OF THE SHARES THE
OPPORTUNITY TO ASK QUESTIONS OF AND RECEIVE ANSWERS FROM THE
COMPANY CONCERNING ANY ASPECT OF THE INVESTMENT AND TO OBTAIN,
TO THE EXTENT DECONTAMINATE INC. POSSESSES SUCH INFORMATION OR
CAN ACQUIRE IT WITHOUT UNREASONABLE EFFORT OR EXPENSE, ANY
ADDITIONAL INFORMATION NECESSARY TO SUPPLEMENT OR VERIFY THE
ACCURACY OF THE INFORMATION CONTAINED IN THIS OFFERING CIRCULAR.

ANY REPRODUCTION OR DISTRIBUTION OF THIS OFFERING CIRCULAR, IN
WHOLE OR IN PART, IS PROHIBITED.


STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
THIS OFFERING CIRCULAR MAY CONTAIN FORWARD LOOKING
STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER
THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY,
AND ITS INDUSTRY. THESE FORWARD LOOKING STATEMENTS
ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND
INFORMATION CURRENTLY AVAILABLE TO THE COMPANYS
MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE
WORDS ESTIMATE, PROJECT, BELIEVE, ANTICIPATE, INTEND, EXPECT
AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD
LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING
STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT?S CURRENT
 VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS
AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY?S ACTUAL
RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD
LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE
RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY
 AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT
UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD
LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER
SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.
THERE IS RISK OF LOSING YOUR ENTIRE INVESTMENT INVESTING IN
OUR COMPANY.

Industry and Market Data
Although we are responsible for all disclosure
contained in this Offering Circular,in some
 cases we have relied on certain market and
industry data obtained from thirdparty sources
 that we believe to be reliable. Market estimates
 are calculated by using independent industry
 publications in conjunction with our assumptions
 regarding the biosurfactant industry and market.
While we are not aware of any misstatements regarding
 any market, industry or similar data presented herein,
such data involves risks and uncertainties and is subject
 to change based on various factors, including those
discussed under the headings ?Statement Regarding
Forward LookingStatements and Risk Factors in this
 Offering Circular.

Offering Circular Summary
This Offering Circular Summary highlights selected
information contained elsewhere in this Offering Circular.
This summary is not complete and does not contain all the
information that you should consider before deciding
whether to invest in our common stock. You should carefully
 read the entire Offering Circular, including the risks
associated with an
investment in the company discussed in the Risk Factors
section of this Offering Circular, before making an investment
decision. Some of the statements in this Offering Circular are
forward looking statements. See the section entitled Statement
 Regarding Forward Looking
Statements.

Summary of Company Information

The Company was organized on August 3 2020 under
 the laws of the State of Delaware.  Our executive offices
 are located at 100 S Ashley Drive Suite 600 Tampa Florida 33602
 and our telephone number is 727 281 1996.
Our website address is www.decontaminate.ai
The information on our website is basic industry information.
 Trade secrets and proprietary information is kept for only a
small group of associates who have signed nondisclosure
agreements.

In 2019 during some initial research, Keith Louis De Santo,
acting as an individual and not for the company completed some
research and was able to detect pathogens viruses, bacteria,
microbes and molds using nanotechnologies and artificial
intelligence on surfaces and in the air. He also completed
research for a rhamnolipid electrostatic spray. Our combination
of nanotechnologies utilizes cantilevers, drones, robots,
sensors and artificial
 intelligence. Our other focus was to eliminate indoor
pathogenic threats using biosurfactants, then to create a
biofilm to deter the formation of microbes. No regulatory
agencies were requested to comment on our applications nor do we
know of any who would comment on Artificial Intelligence
applications.

The Company has obtained that goal before the Covid19 pandemic
 and is able to detect viruses such as Covid19 and Influenza as
well as
E. coli and MRSA. This is done by using high magnification
microscope cameras. The Chief Executive Officer, Keith Louis De
Santo
has primarily self-funded the research and development process
with some financial assistance from a small group of friends and
family.
 The following is an overview of the corporate structure.
Decontaminate Inc is authorized with 100 000 000 common
stock shares and 1 000 000 preferred
stock shares of which 0 common stock shares have been issued.
1,000,000 preferred stock shares have been granted to Keith
Louis De Santo as founders shares.  20,000,000 shares of common
stock with 1 vote per share is being offered for $1.00 per
share.

The Technology

Decontaminate Inc uses nanotechnology combined with
artificial intelligence to detect microbes using drones, robots,
cantilevers and
 machine learning algorithms.
If disease causing pathogens and microbes are detected, we
deploy robots
 and drones to ascertain what application is needed to eliminate
the microbe
threat. We than deploy decontamination drones and robots
utilizing specific
 machine learning algorithms to apply the correct application
such as an
electrostatic rhamnolipid biosurfactant spray with peptides to
break apart the
cell walls of viruses and pathogens. After the correct
application is applied,
biosurfactant mixtures are sprayed on all surfaces to leave a
nontoxic biofilm
 that deters the formation of microbes. After funding we will be
able to
 deploy our
cleaning crew of drones and robots to clean up dirt, dust and
grime.

Conservatively, machines will take over at least 35percent of
the janitorial
 business by 2027. The detection and decontamination business is
presently
antiquated while the janitorial business must be streamlined to
reduce time,
costs, insurance, union fees and mistakes.

4 Components to our business



Detection  what disease causing pathogenic microbes are
present on surfaces and in the air.

Decontaminate  eliminate pathogenic threats

Apply a biofilm  Deter microbe formation on surfaces and in the
air


Cleaning - provide basic janitorial cleaning services


99.8 percent accuracy



The one size fits all decontamination application is antiquated.
Present competition using very little technology, is using one
or two applications that attempt to decontaminate and eliminate
all disease causing microbes.  These pathogenic threats when
misdiagnosed cause disease and may lead to death in humans,
plants and animals. At best, decontamination businesses are
guessing at what the real problem is. We see a different more
exact approach that will complete the job with 99.8 percent
accuracy,
eliminating the guesswork.  Welcome to the world of
Artificial Intelligence AI.

Cantilevers are small nanotechnology weighing machines
that act like a diving board at a pool affixed at one end and
bends
at the other with load. Our cantilevers can weigh microbes in
femtograms 10 to the minus 15 and detect some of the
smallest microbes and viruses such as
 Covid19, influenza, E. coli, anthrax and ricin.
CantiDrones drones imbedded with cantilevers
and CantiBots robots imbedded with cantilevers
in combination with sensors and high magnification microscope
cameras, form
a machine learning platform that utilizes Exascale
computing detection see definition below.

Our cantilevers detect microbes
 pathogens mold bacteria viruses allergens that are present in
 the air and on surfaces that utilize proprietary sensors that
use AI datamining to learn all about our surroundings and the
microbes
 that are present.   After detection, microbe facial recognition
algorithms using high definition pictures and stereoscopic video
 confirm our results gathered from the CantiDrones and CantiBots
 with 100 percent accuracy. In order for our CantiDrones to
datamine
 with high definition pictures and video, we are able to have
our drones attach themselves to walls and ceilings for steady
picture taking. The AI platform also learns where and how to
attach and detach to different forms of rafters,
and lighting.

Exascale computing and pathogen detection and billions of
calculations per second for facial technology for pathogens,
microbes, viruses, molds, and allergens We detect E. coli,
MRSA, Streptococcus, Flu Bugs, Viruses and Pathogenic
bacteria or any matter that has weight and can be photographed.
Data mining   We discover patterns, fingerprints and footprints
 of diseases and contaminating microbes
We can determine if the space is toxic
What is causing the toxicity and how
to eliminate it through machine learning
Our platform can forecast many future events
using AI algorithms i.e. what
company has an issue and what is being done about it.

AI Patent Applications


Patent Application number 62968 410 Using machine learning
algorithms
 and nanotechnology to clean an indoor environment. Provisional

Patent Application number 16828 832 Mobile AI and Cantilever,
Robot
and Drone applications. Non- Provisional

Patent Application number 63041 885 Nuclear Energy power for
detection
and decontamination of pathogens and microbes. Provisional

Neurala AI platforms  Boston, Massachusetts  were utilized to
confirm with
 99.8 percent accuracy that our algorithms worked.  The
algorithms used were
updated and are now owned by the Company.  This was the data
used to file
 the algorithm components of our patent applications.

Domain Names

Cantibot.com			CanitBots.com

CantiDrone.com		CantiDrones.com

DeContaminate.ai		Dusting.ai

Drone-cantilevers.com 	RoboCantilevers.com



Rhamnolipid Biosurfactants




We use a proprietary rhamnolipid biosurfactant electrostatic
spray that
 can break apart the cell walls of pathogens and envelopes of
viruses
leaving a biofilm to deter microbe accumulation. Bacteria
pseudomonas
 aeruginosa secrete chemicals rhamnolipid that fight off and
protect
 themselves from other invading viruses and bacteria.

BIOSURFACTANTS are powerful antibacterial antifungal chemical
agents created by nature that are non-toxic and BIOdegradable
SURFACe
acTive AgeNTs aka biosurfactants as researched and stated in
thousands of
third party periodicals and publications listed on the internet.

We use proprietary mixtures of peptides blended with
biosurfactants to
 eliminate pathogenic microbes and viruses on surfaces and in
the air.

Rhamnolipid, Inc. rhamnolipid production company is also owned
by Keith Louis De Santo.
As on November 2019, the company has developed a lowcost
production
 method to produce
 rhamnolipid at 54 cents a gallon. Competition is at $100/ per
gallon Jeneil.
 The electrostatic rhamnolipid biosurfactant spray application
is a trade s
ecret and patents
will be filed upon funding.

6th Generation of Drones



Because of proprietary technology and trade secrets, we choose
 to showcase basic information on our website. Our 6th
generation
 drone was delivered July 15th, 2020


  Regulatory Filings




By the date of this offering, we should have filed a Regulation
Statement with the SEC. We plan on filing with the United
States Securities Commission SEC through a broker
dealer a secondary Public Offering of our securities after
substantial revenues have been gained. We expect an
IPO in the year 2023 for an investor exit strategy.

Rhamnolipid is registered with the United States Environmental
Protection
Agency EPA
through efforts and costs to Rhamnolipid, Inc.

OMRI Listed Organic Materials Review Institute

CAS Registry number 4348-76-9
Registered with the FDA for ingestion by humans.

State of Florida, Environmental Protection Agency
Registered by Rhamnolipid, Inc.

AI and Microbes and Microbe Clusters


Our machine learning datamining algorithms have begun to
 learn about airborne clusters of matter.  Microbes hitch
 rides on dust particles and other floating matter in the air.
 The Artificial Intelligence platforms are starting to learn
where airborne particles have come from. For instance,
certain industrial complexes rug factories produce certain
 types of fibers. Those fibers attach themselves to other
clusters of matter and microbes floating in the air.
They can travel large distances in the air and on surfaces.
 In certain locations, we may offer an initial scan for free
 under 5,000 square feet. For a fee, our company will pinpoint
the pathogenic microbe and eliminate that the
 Machine Learning algorithms learn
from each scan thereby reducing costs so more people and
 entities in the future can afford our service.

Diseases, viruses and contamination are spread by touching a
surface or object that has a virus disease on it and then
touching
our own mouth, nose, and our eyes. They are also spread
 by airborne particles.  Viruses and diseases pathogenic
microbes
enter our lungs or attach to the mucus of the nose by attaching
themselves
to dust and particles in the air or by being in the vicinity of
another
person sneezing or coughing. Bacteria, allergens and mold spores
form clusters and these clusters attach to airborne particles.
The components of these clusters are
machine learned and these signatures can pinpoint a place where
they
traveled from and forecast where they might end up. Microbe
clusters
are specific to locations across the world. Each cluster
processes a book
of stories about where they have been, what happened and what
may be next.

Individual microbes and clusters of microbes can be identified
by weight
and hi-definition pictures using machine learning.




Marketing, Business development and free scans



Not a day goes by, without a call asking us to scan residences,
businesses,
(a church) and educational facilities (USF). Fear from disease
carrying
microbes (influenza season coming soon), have requests coming in
daily.
 We will begin to transform from a research and development
company
into a revenue producing consumer necessity.  The business was
started before
 the pandemic and recently we are getting many requests without
any advertising.
 We have offered by word of mouth starting cold calling
businesses in
December 2019 a free scan to jump start the business. One recent
request
was from an AI Incubator for free rent in exchange for our
services.
This is not the only form of bartering we have been offered.
Fortunately, we
are at the right time to capture a large portion of the
detection and
decontamination business due to the pandemic.  Funding is the
only
 component needed to expand the business, build the drones
and robots and retain support personal.

Our current marketing campaign is quite basic, cold call, email
and
 send out flyers offering free scans to corporations in large
cities.
By offering a free scan, most scans will produce some data
showing
 some allergens, molds or bacteria.  20 percent of the free
scans may
result in revenues using basic statistical calculations.
Most scans thus far have been for free. The data learned from
each scan will
 be valuable for each new scan provides new data. The costs
involved to
deploy one of our drones to scan a building for microbe
contamination
 is quite low. Initial scans will start in selected large cities
and then branch out.
 In our experience, even if the prospective client does not
engage us to
decontaminate or provide us with a referral, those scans allow
us to build
marketing data for further target markets.Conservatively, we
expect about
5 percent of the free scans may transition into revenues from
referrals.
That trend will continue exponentially as more drones and robots
are
dispatched. Our CantiDrones and CantiBots will continue to
become
smaller while the cleaning drones and robots will increase in
size for
larger jobs. In our calculations, each generation of our
detection and
decontamination robots and drones will be reduced in size by 20
 percent while the cleaning robots and drones will increase in
size
by 4 percent to 7 percent.

The cleaning business will also become much easier. We expect to
 decrease the need for human interaction year by year until
winter 2023
 when the machines will manage 80 percent of the business.
While revenues are increasing, so will be our ability to remove
 human interaction. We are confident
to state that 60 percent  of the janitorial business we serve in
the future
will be serviced by drones and robots. With enough finding we
may be
able to capture most of that business starting in the US, then
world wide.

With our data and applications, we have a high probability to
alert and
maybe eliminate the next pandemic,
 if we are lucky.

Cleaning, Operations and autonomous vehicles



On July 15  2020, our drone technology was advanced to a level
of the sixth generation palm size with 5 sensors.  The power
grabbing
sensors allow us for shorter scan times but more accurate data.
For instance, we detected urine and feces on a lunch table
outside a
restroom.  As we all know, feces and urine when ingested by
humans
 and animals may cause the Norovirus, Hepatitis and other
sicknesses.
The light sensors detected the samples.
intain longer run times which will lead to being efficient
 (less interruption for battery change or charging)
 and more cost effective.  One such power is hydrogen cells
while the other is nuclear energy.  We have
 filed a patent for nuclear energy after we were told by the US
 federal government and the state of Florida
that because of our type of decontamination business, we were
advanced for approval to research nuclear
not be with just batteries.  A hydrogen fuel cell power pack
patent for
 our nanotechnology has been written
and will be filed after funding. Electricity may also be used
and the
electrical cord may be managed by robot
 and drone cord keepers.

The cleaning business ?janitorial? should also become much cost
efficient with higher profit margins for our company. It our
opinion,
 slowly eliminating the need for human interaction will lead to
higher
 profit margins.  While revenues are increasing, so should our
ability
to replace janitorial antiquated systems. We are confident to
state that
60 percent of the janitorial business will be serviced by drones
and robots
 in the next 7 years. With enough funding, we should be able to
capture more of
that business.  We also see the future will be much different
than today.
 One such eliminating factor will be transportation of our
nanotechnologies.
We see that our cleaning drones and robots will get bigger to
allow
for compressed air tanks and refuge tanks for holding dirt, dust
and grime and
depositing that waste in a local dumpster or a landfill located
miles away.
 Our detection drones and robots will continue to get smaller.
Instead of
 transporting our drones to a client site, it is our belief that
they will transport
 themselves through an autonomous vehicle or the robots
themselves will
 also dub as an autonomous vehicle. The drones may also fly
themselves to
a client site. The drones and robots will be stored in
warehouses in major
cities and either disassemble themselves for transport and
resemble themselves
upon arrival at the client site. Drones may disassemble the
robots and reassemble
them at the client site or it may be that the robots disassemble
and reassemble the drones.
 The future of janitorial robots and drones is almost here.

Funding requirements pre money value



Decontaminate Inc. is prepared technologically for what lies
ahead whether
 it?s a pandemic,
E Coli, allergens, fungus, bacteria or a residence with a mold
problem.

The assets of the company are in trade secrets including but not
limited
to Cantilever NanoTechnology, Drone Nanotechnology, Robots
Nanotechnology
and their sensors, proprietary machine learning algorithms as
well as Biosurfactant
Rhamnolipid peptide applications.

Total funding needed for is 22,500,000

Funding requirements in the future through equity may also be
decreased
or eliminated due to immediate revenues and or debt that can be
secured
if needed.  With a successful IPO, worldwide operations can
commence.

Section 2 Artificial Intelligence, Combination Nanotechnologies


How our Service works


Our combination nanotechnology artificial intelligence
applications
work in the following way.

Using artificial intelligence, our company detects and
identifies with
99.8 percent accuracy the exact makeup of microbes and or
clusters
on surfaces and in the air in businesses and residences.
Using artificial intelligence, we then decontaminate with
biosurfactants and peptides Use an electrostatic biosurfactant
spray
 to create a biofilm on surfaces to deter the formation of
microbes.
 After funding, our company will use artificial intelligence
to clean up residences and businesses with basic cleaning
services.

Our drones, robots, cantilevers, and AI algorithms all work in
unison.
The indoor area is first mapped in 3-dimensions by both robots
and drones
where the drones scan the air and the robots scan the ground
area. Information
 ascertained is then fed to the algorithms which
compartmentalizes the data into
3 components. full cubic area in meters, minus the area used by
fixed fixtures
 such as furniture, lights and wall fixtures and total space for
usage as in
unused space.  The drones and robots imbedded with sensors and
cantilevers
see description below then sample the air and surfaces for
pathogens,
bacteria, microbes, molds, gases and allergens to name a few.
The samples are
 induced into cartridges.  The samples are then circulated in
vacuumed
 packed cartridges. The cartridges are either re-usable or
replacement
cartridges depending on the application.

High Definition Pictures

To confirm our data with high accuracy, we use an ai algorithmic
facial recognition platform for microbes. The summarized data is
provided to the client as well as the price to decontaminate.
A separate price is also offered to create a biofilm on
surfaces.
Pictures of microbes detected
will be included in the report to the client.
Cantilevers

Cantilevers are small  nanotechnology diving boards that can
sample
particles in weight of femtograms.

A cantilever is a beam like structure similar to that of a
diving board.
The structure is anchored at one end (usually vertical) and
protrudes
at the other end. A cantilever can also be attached to a flat,
vertical
surface such as a wall. Cantilevers can be constructed with
trusses or
 slabs made of metal, fiberglass or silicone. When subjected to
a weight
at the protruding end, the cantilever bends. That bending is due
to weight.
That weight (measured in femtograms) can be calculated
to determine what the particle may be that is being tested.
Our cantilevers also use light as a measuring device.

Our cantilever uses an array of boards to test particles
in the air. Cantilevers can test hard
or soft surfaces as well as aqueous solutions. Particles
 obtained can be non-toxic, toxic, organic and inorganic.
 Cantilever biosensors are able to detect weight in femtograms.




Drones

Drones used to scan the air in the indoor space in 3
dimensions with use of at least 4 sensors.  Drones
used to detect microbes use cantilevers and other sensors.
  We refer to these drones as CantiDrones.  As of the
date of this offering circular, the company has built 6
 upgrades referred to as our 6th generation CantiDrones.
 Robots

Robots used to scan surfaces in the indoor space in 3
dimensions use 3 sensors.  Robots used to
detect microbes use cantilevers and other sensors.
We refer to these robots as CantiBots.  As of the date
of this offering circular, the company has built 2
upgrades referred to as our 2ond generation CantiBots.

Artificial Intelligence

Who?s better equipped, humans or an AI platform in the
 detection, decontamination and cleaning business.
Alan Turing 1912 to 1954, first one to use artificial
intelligence, stated that there would be continual debate
 about the difference between artificial intelligence
and human intelligence. He realized that asking
whether a machine could think was the wrong question
 The right question is Can machines do what we as
thinking entities can do. And if the answer is yes, isn?t
 the distinction between artificial and original intelligence
 essentially meaningless We ask, can our AI platforms do
 a better job than humans and think and learn at a
 higher rate.  We have already proved that.
In our particular detection, decontamination janitorial
industry, we believe that our array of AI platforms can
do a better job than humans and cheaper.  Most notable
 issues today are human error and people just having
basic bad days and not paying attention to what they
are doing aside from costs by the hour or by the job.
Our algorithms can eliminate many of the decision making
mistakes that humans make. First and foremost, accidental
breaking or damaging of contents in homes or businesses
will be eliminated. Human stress and burnout also factor
in those mistakes. Theft of property and wondering eyes on
 personal belongings will also be eliminated.  Algorithms,
drones and robots tend to be very honest.

Algorithms and Deep Learning

Deep learning is an artificial intelligence function that
 imitates the workings of the human brain in processing
data and creating patterns for use in decision making. Deep
 learning is a subset of machine learning in artificial
intelligence that has networks capable of learning unsupervised
 from data that is unstructured or unlabeled. Deep learning
 is also known as deep neural learning or deep neural networks.


Artificial Intelligence in the personal services business

The future in the janitorial services industry in the United
States
 will be transformed from physical expenditures to machine
 learning through technological breakthroughs. This new way of
combining different technologies to learn how to work alongside
robots, drones and interactive software-based applications is
the
future.  The IDC, (International Data Corporation) predicts that
by
2025, 75 percent of organizations will be investing in employee
 retraining in order to fill skill gaps caused by the need to
adopt
AI. While the first robots in the workplace were mainly involved
with automating manual tasks such as manufacturing and
production
lines, the future of AI, robots and drones see a greater role in
 our personal lives and businesses. As the hardware and
expertise
needed to deploy AI becomes cheaper and more user friendly, we
should start to see AI used in an increasing number of
industries
 such as the agricultural industry.  In the next 3 years, more
and
more devices of every shape and size will start to think and
learn
for themselves and will be embedded into our vehicles,
 household appliances, and workplace tools.  As AI platforms
 become more efficient and capable of running on lower powered
devices, this expansion will continue to become more popular in
2021,
making AI more accessible.

Disrupting the workplace

Artificial Intelligence AI has the potential to improve
productivity, efficiency and accuracy across an organization.
As there is increasing evidence demonstrating the benefits of
intelligent systems, more decision makers in the boardroom
 are gaining a better understanding of what
AI can really offer.

The first companies employing AI systems across the board
will gain competitive advantage, reduce cost of operations and
 remove head counts. While this may be a positive from a
business
perspective, it is obvious why this a worry for those working
in roles at risk of displacement. The introduction of these
technologies will likely trigger an issue with unions and
job security due to the substantial operational changes.
Regardless of how AI is viewed, our AI applications will
 in fact lead to healthier environments in homes and businesses
 while costs will be reduced over time as our platforms learn
more
 about our clients and their environments.

Our new technology of detecting contamination and poor air
quality
and then cleaning the space will lower costs, free them from
many
of the time consuming tasks of cleaning. When polling 200 people
who own homes and manage businesses, 87 percent state they would
pay a higher fee not to have strangers in their homes and
 offices to get their spaces cleaned aside from the drudgery of
 time consuming but essential cleaning and sanitizing.
 Our combination  technologies can be operated from outside of
 an establishment,
down the block for eventually from a remote AI center.

Our incentive to roll out all our products is driven by revenue.
Our AI platform can only grow from those who want a change
their day to day chores. Presently, AI success is driven by the
 success of corporations like Amazon, Facebook, and
 Google, and their ability to deliver personalized experiences
and
recommendations. AI allows providers in real-time as they
interact
 through online portals and mobile apps, quickly learning how
their
predictions can fit our wants and needs with ever increasing
accuracy.
These traits will help our business grow exponentially.

One of the negatives we have come up against is businesses,
organizations and individuals desiring to move towards AI driven
 automated decision making algorithms is privacy. As technology
and methods of knowing all personal habits of residences and
 employees of businesses, processes of masking that
 information have improved and can be reported as code
words that the client chooses and our algorithms can hide.
Accurate data has become increasingly available and reliable
and may need to be camouflaged for the client. Some
personal or company information the platform gains
about the individual or
entity is private and needs to stay that way.   That is why we
sign a non
disclosure before any operations commence.

With our simulation algorithm platform, we can also test our
platforms in
the real world to simulate outcomes for clients that help them
in their
decisions to utilize our AI applications.  Our data shows that
these
simulations will lead to more learning for our platforms.

COVID 19, Influenza and what?s next

The topic of disease prevention gets nearly continuous attention
in
the media, at least in 2020.
Preventing the flu really seems pretty simple: avoid close
contact
with sick people stay home when you are sick cover your mouth
and nose when coughing or sneezing wash your hands often
and avoid touching your eyes, nose or mouth.  With COVID 19
COrona VIrus Disease year 2019, this is a game changer.
 As of the date of this offering circular, some of the cases
were infected by touching surfaces and then touching their
face, eyes, nose or mouth. Though not confirmed, it was stated
that
COVID 19 is also airborne.

COVID-19 is stable for several hours to days in aerosols and on
 surfaces, according to a new study from National Institutes of
Health, CDC, UCLA and Princeton University scientists in
The New England Journal of Medicine. The scientists found
that severe acute respiratory syndrome coronavirus
2 SARSCoV 2 was detectable in aerosols for up to three
 hours, up to four hours on copper, up to 24 hours on
cardboard and up to two to three days on plastic and
stainless steel. The results provide key information
about the stability of SARS CoV2, which causes
 COVID19 disease, and suggests that people may
acquire the virus through the air and after touching
contaminated objects.
As with the flu, people will keep getting sick. According
to the U.S. Centers for Disease Control (CDC), 20 percent
 of Americans will come down with the flu each winter. Of
course, it?s impossible to stop everyone from getting the flu,
 but even if a company were to just reduce the incidence of
flu among its workers, it could make significant improvements
 in the well-being and productivity of its workforce.
 Most experts believe that flu viruses are spread mainly by
droplets produced when infected people cough, sneeze or talk.
 These droplets land in the mouths or noses of other nearby
 people. A person can also get the flu by touching a surface
 or object with flu virus on it, then touching their own mouth,
 eyes or nose. As a result, cleaning and disinfecting surfaces
and objects that may be contaminated with flu germs can help
 slow the spread of influenza. In other words, management
practices and intensive cleaning programs can help knock out
 flu germs before they infect workers.  We concern is also
focused on what we don?t know such as future pandemics
and strains of diseases that antibiotic resistant.

In addition to personal behavior and company policies, regular
and thorough cleaning of the workplace is essential to
controlling
 the transfer of germs and viruses. Since germs and viruses are
spread by infected people, the germs go anywhere people do.
As a result, companies must focus on facility-wide cleaning
strategies that thoroughly disinfect surfaces including their
phones keyboards and keys.  Biosurfactant wipes will
eliminate that problem and maintain a non-toxic healthy biofilm.

Breakrooms where food is consumed and restrooms are a
breeding ground that helps grow and spread bacteria and
fungus.  The next culprit of spreading germs and viruses
are keys, mice and soles of shoes.  Routine disinfection
of these surfaces is vital to a healthy surrounding.

Surfaces that breed germs and viruses usually don?t get
 the attention they should.  Our AI algorithms are specifically
designed to not only pay close attention to those surfaces,
 but learn what is on those surfaces. Coronavirus, influenza,
and the common cold are respiratory viruses. While coughing
 and sneezing are their main routes of transmission, infected
 surfaces such as computer keyboards, touchscreens, and bathroom
 handles can also transmit disease. The rhinovirus the virus
that causes
 the common cold remains infectious on household items for up to
18 hours such as doorknobs and remote controls.
Influenza also poses a risk on surfaces. In one study, the
influenza
virus remained infectious on stainless steel surfaces for up to
eight
hours. Other studies suggest that it might persist for as long
as a week.
Survival on porous surfaces is much shorter, from as little as a
few
minutes for cloth or paper to as long as 48 hours on wood.
How can you treat a surface if you don?t know what your treating
question
 mark We treat the surfaces with Rhamnolipid. We have research
that shows
 our combination of rhamnolipid with other non-toxic EPA
approved
chemicals not only kills Covid19, Flu germs and other diseases
on surfaces,
but is cheap enough to produce with our production breakthrough
to
compete with other products currently on the market. Our
Rhamnolipid
applications not only clean and disinfect with a non-toxic
application,
 but our products also leave a biofilm to deter bacteria, fungus
and
viruses from adhering to surfaces.

We believe that it is just a matter of time before the EPA bans
some
chemicals that cleaning services use.  Current cleaning
processes may
 leave behind airborne and surface-bound residual chemicals that
may
cause irritation and possibly sickness to people.  The trend
toward
environmentally preferable cleaning has changed the type of
cleaning
 products many
 companies use regularly, according to the International
Sanitary
Supply Association ISSA.

It is unlikely that germs, viruses, and fugus will ever be
completely
eliminated in offices and homes in the near future but, our AI
platform
will greatly reduce the spread and infection rate.  It is our
aim to
completely stop the spread of these viruses  through our new
machine learning algorithms.


Indoor Contamination and Air Pollution

Pollution is defined as the introduction into an environment
indoor
and outdoor of living or nonliving matter that is harmful to
living organisms.

Contamination is defined as the presence of a substance that
should not be
 present naturally.

An environment can be contaminated without it being polluted,
but cannot be
 polluted without it being contaminated.

Types of Pollution

Mold
Pollen
Tobacco smoke
Pet Allergens
Pesticides
Gases such as radon and carbon monoxide
Materials used in the building such as asbestos,
formaldehyde and lead.
Paints, paint strippers and other solvents
Wood preservatives
Aerosol sprays
Cleansers and disinfectants
Moth repellents and air fresheners
Hobby supplies
Dry-cleaned clothing
Building materials and furnishings
Office equipment such as copiers and printers, correction fluids
 and carbonless copy paper
Graphics and craft materials including glues and adhesives,
 permanent markers and photographic solutions.


EPA's Office of Research and Development's Total Exposure
Assessment
Methodology TEAM Study Volumes I through IV, completed in 1985
 found levels of about a dozen common organic pollutants to be 2
to 5
times higher inside homes than outside, regardless of whether
the homes
were located in rural or highly industrial areas.
Volatile organic compounds VOCs
Volatile organic compounds VOCs are emitted as gases from
certain
 solids or liquids. VOCs include a variety of chemicals, some of
which
may have short and long term adverse health effects.
Concentrations of
many VOCs are consistently higher indoors up to ten times higher
than
outdoors. VOCs are emitted by a wide array of products numbering
in the
 thousands.

Organic chemicals are widely used as ingredients in household
products.
Paints, varnishes and wax all contain organic solvents, as do
many cleaning,
 disinfecting, cosmetic, degreasing and hobby products. Fuels
are made up
 of organic chemicals. All of these products can release organic
compounds
while you are using them, and, to some degree, when they are
stored.
Studies have found that levels of several organics average 2 to
5 times higher
indoors than outdoors. During and for several hours immediately
after certain
activities, such as paint stripping, levels may be 1,000 times
more than
outdoor levels.
Health effects may include
Eye, nose and throat irritation
Headaches, loss of coordination and nausea
Damage to liver, kidney and central nervous system
Some organics can cause cancer in animals, some are suspected
 or known to cause cancer in humans.
Key signs or symptoms associated with exposure to VOCs include
conjunctival irritation
nose and throat discomfort
headache
allergic skin reaction
dyspnea
declines in serum cholinesterase levels
nausea
emesis
epistaxis
fatigue
dizziness
The ability of organic chemicals to cause health effects varies
greatly
from those that are highly toxic, to those with no known health
effect.
As with other pollutants, the extent and nature of the health
effect
will depend on many factors including level of exposure and
length
of time exposed. Among the immediate symptoms that some people
have experienced soon after exposure
to some organics include
Eye and respiratory tract irritation
headaches
dizziness
visual disorders and memory impairment

Sick Building Syndrome


Sometimes a group of people have symptoms that seem to be linked
to
 time spent in a certain building. When they leave the building
for the
day, the symptoms go away. There may be a specific cause or the
cause
of the illness cannot be found. This is known as Sick Building
Syndrome
 SBS.

Usually indoor air quality problems only cause discomfort. Most
people feel better as soon as they remove the source of the
pollution.
 However, some pollutants can cause diseases that show up much
later,
 such as respiratory diseases or cancer.Have you and your
coworkers
been feeling sick without being able to put finger on your exact
illness
or what causes it question mark If yes, then you are probably
suffering
from Sick Building Syndrome SBS, a collection of various
symptoms
and illnesses due to poor air quality in a building or shared
confined space.
This occurs only during office hours and affect two out of every
10
 employees. The symptoms usually improve after leaving the
building and
come back when the person returns to the workplace.
Employees spend a minimum of eight to 10 hours of their
day at work. It is the place
 where they spend most of their time away from their homes.
 A healthy environment
 not only improves employee?s performance, but also their
 mental attitude. We can improve
 the overall experience in the working environment with
our cost efficient uninstructive applications.

AI Decontamination  Biosurfactant Overview

Most of the research completed was focused on viruses
 including the Corona Virus COVID 19 and Influenza.

The interaction between antimicrobials is synergistic when the
combined activity is greater than the additive effect of the
antimicrobials.
 Our Biosurfactant formula Rhamnosan was specifically
designed to be broad spectrum and highly effective against
gram positive and gram negative pathogenic bacteria, pathogenic
 fungus, pathogenic viruses including COVID19 and flu
 viruses and degrade other biofilms.

Rhamnolipid Biosurfactant - Starting with the biosurfactant
Rhamnolipid  also known as RL. RL reduces the surface tension
between the solution and the surfaces it is sprayed on.
This allows the antimicrobial solution to better penetrate the
surface
it is sprayed on. RL acts as a detergent interacting with
bacterial
 and virus membranes. RL interacts with lipid bilayer of gram
negative bacteria increasing the negative charges on the cell
surface which allows the cationic positive charged antimicrobial
organic peptides to greater adherence and faster penetration
into the microbes causing cytoplasm breakdown and
quick cell death. Below is an illustration showing rhamnolipids
ability to remove the lipopolysaccharide membrane LPS,
disintegrate the cell membrane creating an opportunity for other
ingredients to additively break down
and permeabilize the cell wall and penetrate into the cytoplasm
for an
irreversible death.



Antimicrobial small peptides - There are multiple mechanisms of
action
for these cationic positive charge groups. They are able to
disrupt the
bacterial cell membrane and when combined with other
antimicrobials
can penetrate into cells causing cytoplasmic disruption. The
antibacterial
 effect of these peptides are dependent on the ability of
multiple charges
to attach to and interact with the cell membrane. These charges
are
synergistically enhanced by rhamnolipid and other peptides.
There is further cell penetration by the organic acids in
solution that
attack the cell wall, helate minerals and dissociate within the
cell cytoplasm.



Organic Acids
There are many antimicrobial organic acids.
Some are considered weak. Weak acids
 are most effective in their undissociated form.
This is because once inside the cell,
the acid dissociates goes into solution
because the cell cytoplasm interior has a near
 neutral pH.
 Protons generated from intracellular dissociation
of the organic acid H plus turn the
 cytoplasm acidic and must be removed by the
organism. The cytoplasmic membrane is
impermeable to H plus protons and must be actively
transported to the exterior of
the cell.

This causes the cell to use tremendous energy to pump out
 the constant influx of these
 H plus protons which will eventually exhaust
the microorganism leading to death.

This solution combines organic acids allowing the
pH to be more effective as the
 acids have different
pKa values where the acid is 50 percent in solution
and 50 percent not in solution
and since each of the acids act upon gram negative
 and gram positive
 bacteria differently their combination allows for better
 cell membrane
penetration. The complex combinations
of organic acids create a synergistic reaction present as a
powerful
antimicrobial at low concentrations. Broad spectrum
activity and is effective against
bacteria, both gram positive
and gram negative and viruses.

Physical Application

Using cantilevers black light Infrared Light and other sensors,
 we are able to
 scan bacteria and viruses and their cells.
We can then capture a biochemical
makeup of cells and their identity.
Then we forward that hard data to our AI
platform that decides on the following

Spray the rhamnolipid application with a nozzle
 from our drones or robots on
 specific targeted areas, or
using a misting device specifically designed for
 drones and robots that covers
the entire area using an electrostatic spray.
Electrostatic spraying is an
 application where an electric charge is
added to our application in
order to have it cover an entire surface.

Superbugs, Viruses and Rhamnolipid

Rhamnolipid can break apart the cell walls of
many pathogens and viruses including but not limited to E.
Coli, Flu Bugs and the Covid19 virus. The antimicrobial
application creates cell membrane permeability and
eliminates pathogens on surfaces. Our application
also forms a biofilm from our electrostatic spray
 which creates an anti-microbial biofilm from 5 to 30 days
depending on the surface.  This application is nontoxic,
is EPA registered and environmentally safe.

Superbugs are strains of bacteria, viruses, parasites and
fungi that are resistant to most of the antibiotics and
other medications commonly used to treat the infections
they cause.  Basically, superbugs have adapted and become
 resistant to most types of antibiotics used to treat the i
nfections they cause.

Viruses are the smallest known type of infectious agent,
smaller than bacteria.  Viruses are not living cells and they
 need to inject themselves into healthy cells to survive and
reproduce.

Superbug pseudomonas aeruginosa is a common pathogen of
healthcare associated infections, causing high mortality in
immunocompromised patients.  Another example is the
 Flesheating disease Necrotizing Fasciitis where surgical
removal of dead or infected tissue from the wound is often
required whereas antibiotics are ineffective.  What people
call superbugs have appeared partly because of the natural
evolution of germs. Infectious germs, such as bacteria, multiply
very quickly. This allows them to overpower the body?s immune
 system and cause an infection.

What the public should know is that the more antibiotics
 youve taken, the higher your superbug risk, says Eric
 Biondi, MD, who runs a program to decrease unnecessary
antibiotic use. "The more encounters you have with a hospital
setting, the higher your superbug risk.  Stronger strains of
 these bacteria have become antibiotic resistant and have
little or no response to antibiotics.

What Causes Infectious Diseases

Microbes that cause disease are called pathogens.
 Many diseases are caused by microscopic microbes
organisms called pathogens.  Pathogens live in or on
another organism and derive nourishment from it.
Viruses the smallest known type of infectious agent smaller
than bacteria but are not living cells where they inject
themselves into healthy cells to survive and reproduce.

The Spread of Pathogens and Viruses

Pathogenic airborne infections.  Airborne diseases are
caused by tiny pathogenic microbes that are transferred
to particles in the air such as dust and discharge from an
 infected persons respiratory system.  Discharges from an
 infected person can be from close contact after coughing,
sneezing, laughing.  The discharged microbes remain
suspended in the air on dust particles and water droplets
 for quite some time depending on the amount of draft
in the surrounding area.  The common cold and influenza
are spread this way.

Pathogenic surface infections. Pathogens are also spread
 by simply someone touching or leaving bacteria on a surface
 that someone else touches.  Shaking hands is also a vector of
 transfer and after the COVID19 pandemic may become a thing
of the past.  Doorknobs serve as reservoirs of bacteria and
viruses
 that can easily transfer to the hands through direct contact,
which in turn can be easily transferred to the lip, the eyes and
the nose through a simple touch. Infection in hospitals and
 nursing homes are spread very easily by doctors, nurses, or
 other healthcare professionals who touch people, objects, or
surfaces in facilities where they live.

Rhamnolipid are Biosurfactants, or Surfactants
SURFACe acTive AgeNTS.
Biosurfactants are naturally produced by bacteria to defend
themselves against other invading bacteria. Because rhamnolipid
 has both hydrophilic and hydrophobic components, rhamnolipid
facilitates its entry into cell membranes by breaking down the
cell
wall of bacteria.  We initially plan to use our biosurfactant
rhamnolipid
application in hospital settings, nursing
 homes, airliners and trains.


Section 3 Janitorial Services Industry



Present Industrial Cleaning Business

The Company provides a necessity, not a luxury.
That?s the way
 we look at it.  The company offers a different way
of doing business that is less expensive and more reliable.
 With our drones, robots and software engineers, we can
do a better job than janitorial workers can with 100 percent
accuracy.

The Service Employees International Union SEIU represents
2.2 million union workers. It is safe to say that either way,
our
service will cost less as our AI platform learns all aspects of
the business.


Present Janitorial Industry Costs

Commercial cleaning companies provide services for
a wide variety of properties such as offices, schools,
medical facilities, restaurants, retail locations, churches
 and more. The average price for commercial cleaning
companies depends. Some are for a onetime service
while others use cleaning services once a week or many
times a week. The costs are broken down in the following
segments

The number of windows, bathrooms and where the cleaning crew
unloads among other things adds or subtracts from the total
cost.
 In an office building, windows, bathrooms and break rooms or
 kitchens generally take longer to clean and disinfect than
hallways,
 offices or waiting rooms. The greater the number of windows to
be
 washed and the higher-traffic areas to be cleaned, the greater
the total
cleaning cost will be.

OneTime Commercial Cleaning Rates Chart for September 2019
 Janitorial services


httpswww.thumbtack.com

Residential

1 bedroom 1 bathroom
Standard cost 		100
Deep Cleaning		125
Move out cleaning	175

3 bedroom 2 bathrooms
Standard cost 		150
Deep Cleaning		175
Move out cleaning	175

Per square foot

1,000 		80 to 125
2,000		100 to 200
3000		150 to 300


Commercial

Janitorial services revenue in the U.S reached 61
billion in 2018. Most of this revenue is generated by c
ommercial enterprises such as schools, healthcare
establishments, office, and religious facilities.

Rates range hourly from 20.00 to 50.00 for offices
1,200 to 2,000 square feet.   This includes emptying
the trash, dusting and vacuuming.


Square Feet				Commercial Cleaning Costs one time

0  1000		sq. ft				118

1000  2000		sq. ft 				150

3000  4000		sq. ft 				200

5000  6000		sq. ft 				224

7000  8000		sq. ft 				400

9000  10000		sq. ft 				463


Flat Rates

Some commercial cleaning companies charge a flat
 rate to clean a commercial space. Generally, they will do
a site visit and walkthrough to determine about how many
 employees will be needed and how long the job will take.
Residential and Commercial Cleaning in Bridgeport
 Connecticut assesses the square footage, number of
 rooms and type of rooms, and then breaks down
the job by the hour to provide a price quote to clients.

Commercial Cleaning Hourly Rates

According to residential and commercial cleaning data,
cleaning rates of 30 35 per worker per hour represent
an average range. Companies that charge by the hour
may provide a free cost estimate based on a walkthrough
and the number of hours they think it could take to clean
a space. This cost estimate can vary after the job is complete,
 and the time it takes to clean the same space may vary
affecting cleaning costs.

The number of windows, bathrooms and where the cleaning crew
 unload among other things adds or subtracts from the total
cost.
In an office building, windows, bathrooms and breakrooms or
kitchens generally take longer to clean and disinfect than
hallways,
 offices or waiting rooms. The greater the number of windows to
be
washed and the higher-traffic areas to be cleaned, the greater
the total
 cleaning cost will be.


Commercial Cleaning Rates Chart for Janitorial services


www.thumbtack.com/p/house-cleaning-prices






How we offer our services

We categorize our services into 3 components

Section 1 TYPE - what type of facility

Corporate
Corporate Office
Retail Space  Store
Non Corporate
School
Religious Institution
Municipal Facility
Industrial Facility
Warehouse
Auto Repair Garage
Manufacturing
Food preparation
Residential
Residence
Residence with Garage


Section 2 SIZE - By size of facility

Small facility up to 5,000 square feet
Medium facility from 5,000 to 25,000 square feet
Large facility over 25,000,000 square feet

Section 3 ?SEVERITY-Severity of Contamination/Air pollution:

Scale ranges from 1 to 10, where 10 is most severe and the
facility or
residence should be quarantined.



Basic Pricing for our services

Our fees are based on two different models

Basic Scans that are general in nature.  Basically, is the space
toxic of not

Cost is 99.00 an hour.


99.00 an hour is based on a space of 1,000 square feet.

Residential Scans are specific for food particles, molds and
floor
pathogens brought in by soles of shoes.

Cost is 149.00 an hour.


Business Scans are specific for type of business corporate,
Industrial, warehouse, hospital, food processing and floor
pathogens brought in by soles of shoes.


Cost is 249.00 an hour.


249.00 an hour is based on a space of 2,500 square feet.


Pricing for Severe Decontamination


Pricing severe decontamination is based on a case by case basis.
We charge a flat fee 2,250 per hour regardless of size of space.
Pathogens may be isolated to a specific area or may be
ubiquitous.

Pricing for Biofilm Application


Pricing is dependent upon what has been detected and
what type of threat it poses
We may charge a flat fee where the client skips the detection
 and decontamination scans and requests a biofilm application
after another entity has cleaned the premises. We charge a flat
of 249 an hour without making any promises or statements that
 the premise is clear of pathogens.

Present Marketing

Currently, we use 3 methods of advertising to gain market share.

Cold calling residences and businesses offering free scans
Sending out flyers via email and regular mail
Showcasing out technology for hospitals and assisted
living facilities.

We serve the greater Tampa area and will expand into large
cities after funding in Phase II.
Phase I expansion will consist of large cities such as Orlando,
Miami and Tallahassee in the State of Florida.

Phase III expansion will consist of the United States
Phase IV expansion will consist of Canada and South America
Phase V expansion will consist of worldwide operations
commencing in Europe.

The Company?s present marketing strategy is cold calling
residences and
businesses offering free scans.  Potential clients that we
performed free
scans for we ask for referrals in return for a discount on their
next scan
or decontamination.

Most potential clients we sign a non-disclosure with.  If we
find pathogens
 or other issues, disclosing that information may cause the
homeowner or
 business negative consequences and we may become a party to a
lawsuit.
Only 4 people have access to the data from scans which includes
the client.
Some data on the report to the client will be replaced with
?other? language.


Phase I Marketing.

After funding, we plan to buildout the websites focusing on
advertising
in expanded cities.  We also plan to advertise on social media.

Interactive Client Center

There are 2 ways our algorithms interact, learn and gain sales
data
about our clients and prospective clients. Interactive
applications through
 our mobile or desktop application algorithms or in person with
our robots.


Use of Proceeds

Each Nano-Technology Combination NT Combo application consists
of a robot, drone, cantibot (embedded with a cantilever and 7
sensors),
cantidrone, embedded with a cantilever and 11 sensors, and a
laptop.
Total of five components needed for either detection scan and/or
decontamination of premises.


7,925,000 25 nanotechnology combination packages
 first order 3 months to complete
7,925,000 for second order of 25 nanotechnology
combination packages 3 months later
3,100,000 AI Software revisions aligned with technology upgrades
1,300,000 C level Executives and office support staff, clerical
600,000 Patent filings, maintenance and prosecution, PCT, Legal,
Accounting
1,500,000 working capital.

Total funding to be raised 25,000,000
Possibly 6.5 to 10 commission 2,500,000
Use of Proceeds

For scenarios of 25 percent, 50 percent, 75 percent and 100
percent funded

$5,000,000 25 percent
$10,000,000 50 percent
$15,000,000 75 percent
$20,000,000 100 percent

Each Nano-Technology Combination NT Combo application consists
of a robot, drone, cantibot (embedded with a cantilever and 7
sensors),
cantidrone, embedded with a cantilever and 11 sensors, and a
laptop.
Total of five components needed for either detection scan and/or
decontamination of premises.

The cost of each NT Combo application is $317,000
Artificial Intelligence algorithm expansion and upgrades totals
$3,100,000 and $1,300,000 C level Executives and office support
staff, clerical $600,000 Patent filings, maintenance and
prosecution, PCT, Legal, Accounting and $1,500,000 working
capital.

At 25% funding for $5,000,000, the funds will be used in the
following manner
$951,000 3 NT Combos
$3,100,000 AI expansion
$200,000 patent and legal
$500,000 C level Executives and office support staff,
$60,000 Rent warehouse space
$140,000 working capital.

At 50% funding for $10,000,000, the funds will be used in the
following manner
$3,804,000 12 NT Combos
$3,100,000 AI expansion
$600,000 patent and legal
$1,300,000 C level Executives and office support staff,
$400,000 Purchase warehouse
$796,000 working capital.

At 75% funding for $15,000,000, the funds will be used in the
following manner
$8,876,000 28 NT Combos
$3,100,000 AI expansion
$600,000 patent and legal
$1,300,000 C level Executives and office support staff,
$400,000 Purchase warehouse
$796,000 working capital.


Total funding to be raised $20,000,000
At 75% funding for $15,000,000, the funds will be used in the
following manner
$12,680,000 40 NT Combos
$3,100,000 AI expansion
$600,000 patent and legal
$1,300,000 C level Executives and office support staff,
$400,000 Purchase warehouse
$1,920,000 working capital.


Risk Factors

There are many risks involved in investing in new issue
 securities such as our company.
The following risk factors are not meant to be all encompassing,
but rather highlights
 some of the more significant factors that investors face in
investing
 in our company.
The information contained herein is not intended as a discussion
of
the merits of the
 artificial intelligence and biosurfactant industries, but an
overview
of emerging
technologies and applications that may mature. You must perform
your own
evaluation or what that of industry professionals of whether
purchasing securities in this offering is consistent with your
 investment objectives, risk tolerance, and
financial situation.
There are a variety of risk factors typically associated with
investing
 in new companies in new industries, any one of which may have a
material and adverse effect on if the company will in fact
achieve
success in the marketplace. These include the following:
Company?s Lack of Operating History. A Company that engages in
 a public offering may be in the early stages of development
with
a history of no revenues and may operate at a loss for quite
some
time and are typically subject to the difficulties,
uncertainties, and
risks associated with the establishment of a new business such
as
gaining market share, artificial intelligence capability and
acceptance in the public domain, limited product lines, lack of
marketing expertise, the existence of more experienced or better
capitalized competition, and reliance on a few large suppliers
or
customers. No Prior Market for our Common Stock
 Determination of Offering
Price Potential Volatility. Prior to an offering, there is
generally no
public market for an issuer?s common stock and there can be
 no assurance that an active trading market will develop or be
sustained following the offering. The offering price of
securities stated
in this offering was determined by what is needed to enter the
industry
and that may change.

Dilution
If the stock of the company does trade, the securities may
be subject to significant fluctuations in response to numerous
 factors such as lack of liquidity, general market volatility,
and other factors unrelated to the operating performance of the
company. Additional Financing. A company that operates at a
 loss or with limited cash flow following an offering will
generally be required to secure
additional financing in order to fund its operation.
If the issuer decides to issue additional equity securities, it
is possible that their issuance will result in dilution of the
interests
of existing shareholders, including those who had purchased in
this offering.
 To the extent that the issuer incurs indebtedness, the issuer
will be subject
to certain risks including interestrate fluctuations and
inability to
generate sufficient cash flow to make scheduled payments.
In addition, indebtedness generally ranks prior to
the common stock of an issuer for purposes of distributing the
issuer?s
assets in the event of bankruptcy. There is also the possibility
that the
issuer will be unable to locate financing on satisfactory terms
or may
 be required to significantly curtail its operations.
Dependence on Key Personnel. An issuer is often highly dependent
on
the services of key technical and management personnel and loss
of their
 services could have a material adverse effect on the issuer?s
business or
 operations.
Proprietary Rights and Licenses. Because our company depends on
patent
protection and proprietary trade secrets in our operations, our
success is
 directly related to our ability to obtain and enforce
intellectual property
protection for such technology if granted. There exists the
possibility that
certain patents would not be sufficiently broad to protect key
aspects of
our business, so that competitors would be able to duplicate our
processes
or that patent laws would not provide effective legal or
injunctive remedies
to prevent infringement. Patents are also frequently challenged,
invalidated,
 or circumvented by competitors; litigation of patent or
infringement claims
 may result in substantial cost and diversion of resources.
Business Expansion interruption or not obtained.
 Rapid and substantial demand for our products may lead to
delays in filling
 orders and meeting scheduled scans
.. Such delays, if recurring, can increase the risk that
customers will cancel
 our services and seek other options. To the extent that our
company seeks
to expand to meet demand, the costs and ability of doing so may
be
underestimated.
Dependence on Key Suppliers. Our company relies significantly on
a limited
group of suppliers to obtain product components or materials. If
our company
 is unable to obtain sufficient quantities or such components or
materials fail to
 meet specifications, delays or reductions in shipments may
hamper our ability
to keep deadlines and meet client expectations. We nay not
recover from this
type of damage to our reputation
Dependence on Limited Number of Customers. Our primary customer
base is
 limited to a small number of customers for lack of resources,
loss of any one
of which could have a material adverse effect on our business
and financial
condition.

Competition. companies experience significant competition in
their product lines
from other companies, including larger companies which have
access to greater
financial, technical, and other resources. It may be difficult
for our company to
continue to make investments necessary to maintain its
competitive position.
Rapid Technological Change. Companies in the present technology
field of
artificial intelligence face constant technology innovations
from other entities.
 Our technology is subject to future technologies will render
our products or
technologies obsolete. Our company may be unable to develop or
introduce
new products or enhancements to existing products and processes
in a timely
manner to achieve market acceptance, satisfy client needs or
compete with new
technology innovations.


Management

The founder of Decontaminate Inc is Keith Louis ? DeSanto.
Keith has a Bachelor of Science in Mathematics form Northeastern
University in Boson MA. Keith has worked in the financial
Industry since graduating college and has since owned Goldes
Securities CRD 115-248, a FINRA registered Broker Dealer.  Keith
also owns Rhamnolipid, Inc. a Biosurfactant company and can be
viewed at www.rhamnolipid.com Keith owns 1,000,000 shares of
preferred stock with voting rights of 250 votes per share and no
common stock shares.


After the first round of funding, C level individual positions
will be filled as well as clerical positions.

Board of Directors

The Board of Directors consists presently of the founder, Keith
Louis De Santo.
  There will be 8 other seats to fill after funding.  The board
should consist of 4 individuals who the funders choose and 4
different industry professionals from the janitorial industry,
the AI industry, banking industry and the tech industry.

Officers.  Keith Louis De Santo will be the CEO of the company.
Compensation for the CEO will be $100,000 per year. Keith has a
Bachelor of Science degree in Mathematics from Northeastern
University. Keith has worked in the financial industry since
1989.
Contact Information

www.decontaminate.ai

Decontaminate Inc.
100 Ashley Drive S
Suite 600
Tampa, Florida 33602
7272811996



Financials Exhibit A


Plan of Distribution.
If we decide to use a broker Dealer, we will update this
Offering Circular.


This offering circular does not disclose trade secrets,
proprietary formulas,
 sensors or specific
application information.

/Keith Louis De Santo/ CEO, CFO and Sole Director

PART II AND III

Subscription Agreement Decontaminate Inc


Please carefully read all instructions and the terms and
conditions of our Regulation A Offering Circular dated,
September 1, 2020, as filed with the Securities and Exchange
Commission (the ?SEC?). The Regulation A (as amended or the ?Reg
A?), was filed and is pending approval from the SEC. The
Subscription Agreement must be completed and signed before this
subscription for equity is considered.  Capitalized terms used
and not otherwise defined herein shall have the meanings set
forth in the Reg A Offering Circular.  If you need assistance,
please call your advisors or call us.

Minimum Investment
$1.00 per share of common stock
$20,000 or 20,000 shares

Your answers to the questions contained herein must be true and
correct in all respects, and a false representation by you may
constitute a violation of federal and state securities laws.
When the Subscription Agreement is complete, the company will
plan to pick up the check and subscription agreement or you may
use our account with Federal Express using account number 2522
70116 and send to:
Decontaminate Inc
100 S Ashley Drive Suite 600
Tampa, Florida 33602
(727) 281-1996


Make checks payable to:
?Decontaminate Inc?
Or wire to:
Account Name:  Decontaminate Inc
Bank Name:  Wells Fargo Bank
Bank Address:  420 Montgomery Street, San Fran 94104
Routing Number:  121000248
For Credit to TD Ameritrade clearing
Account Number:  4123214561

For the Benefit of Decontaminate Inc
Account number 277240835
100 S Ashley Drive, Suite 600
Tampa, FL 33602




Covenants and Certifications
I certify that the information contained herein is true and
correct in all material respects and may be relied on by the
Company.
Under penalties of perjury, I certify that: (i) my taxpayer
identification number, address, email address, phone number and
date of birth shown in this Subscription Agreement is correct
and;
A.	Review of Information.  I have been furnished with and have
carefully read the Regulation A Offering Circular dated
September 1, 2020 ?Reg A? and the exhibits and any supplements
attached thereto prior to making a decision to invest in the
common stock equity of the company.
B.	Survival. I agree that the representations, certifications,
and agreements set forth in this Subscription Agreement shall
survive the purchase and delivery of the common stock (equity).
C.	Restricted Securities.  I understand that the investment in
the equity is an illiquid investment.  In particular, I
recognize that the investment has many clearly stated risks that
are listed in the Reg A and;
D.	Termination.  I agree that this subscription is and shall
be irrevocable, but my obligations hereunder will terminate if
this subscription is not accepted by the Company.
E.	Miscellaneous. I represent and warrant to the Company that:
I have carefully reviewed and understand the risks of, and other
considerations relating to, a purchase of equity;
I have been afforded the opportunity to obtain any information
necessary to verify the accuracy of any representations or
information set forth in the Reg A and have had all inquiries to
the Company answered, and have been furnished all requested
materials.
I have not been furnished any offering literature by the Company
or any of its affiliates, associates, or agents other than the
Reg A, and the documents referenced therein;
I am acquiring the equity for which I am subscribing for my own
account, as principal, or for investment and not with a view to
the resale or distribution of all or any part of the Equity or
underlying securities;
All of the information which I have furnished to the Company or
which is set forth in the Subscription Agreement is correct and
complete as of the date of the Subscription Agreement.  If any
material change in this information should occur prior to my
subscription being accepted, I will immediately furnish the
revised or corrected information;
I further agree to be bound by all of the terms and conditions
described in the Reg A; and
I am the only person or principal with a direct or indirect
interest in the equity subscribed for by the Subscription
Agreement.
I am aware that no federal or state agency has reviewed or
passed upon the adequacy of the offering of equity, made any
finding or determination as to the fairness for investment, or
any recommendation or endorsement of the equity as an
investment.
I agree to indemnify and hold harmless the Company and its
officers, directors, employees, agents, and affiliates from and
against all damages, losses, costs, and expenses (including
reasonable attorneys? fees) that they may incur by reason of the
failure of the undersigned to fulfill any of the terms or
conditions of this Subscription Agreement, or by reason of any
breach of the representations and warranties made by the
undersigned herein, or in any document provided by the
undersigned to the Company.
This subscription agreement and the rights granted hereby are
not transferable or assignable by me without the written consent
of the Company.
If more than one person is executing this document, the
obligations of each shall be joint and several and the
representations and warranties contained in the Subscription
Agreement shall be deemed to be made by, and be binding upon,
each of these persons and his heirs, executors, administrators,
successors, and assigns.
This subscription, upon acceptance by the Company, shall be
binding upon my heirs, executors, administrators, successors,
and assigns.
The Subscription Agreement shall be construed in accordance with
and governed in all respects by the securities laws of the State
of Florida without giving effect to the principles of conflicts
of laws.
Any notices to be given hereunder may be given and shall be
effective as follows: to the Company at its principal place of
business located at 100 S Ashley Drive Suite 600, Tampa, FL
33602 and emailed to keith@decontaminate.ai; and to the
Investor, at their address and email address appearing in this
subscription agreement.  Notices by personal delivery shall be
effective upon such delivery that may be sent by a nationally-
recognized overnight courier, such notice to be effective at
time of delivery or attempted delivery upon production of proof
of same; and notices may also be sent by registered or certified
mail, return receipt requested, and shall be effective three
days after mailing, upon production of proof of receipt or of
attempted delivery.

BY SIGNING, I ACKNOWLEDGE THAT I HAVE RECEIVED AND CAREFULLY
REVIEWED THE REG A OFFERING CIRCULAR DATED SEPTEMBER 1, 2020 AND
THAT I HEREBY AGREE TO BE BOUND BY THE TERMS OF THIS
SUBSCRIPTION AGREEMENT.
INDIVIDUAL ACCOUNTS
_______ I am a non-accredited investor. A non-accredited
investor is anyone making less than $200,000 annually (less than
$300,000 including a spouse) that also has a total net worth of
less than $1 million when their primary residence is excluded.
I certify that I am an ?accredited investor? because:
_______ I had an individual income of more than $200,000 in each
of the two most recent calendar years, and I reasonably expect
to have an individual income in excess of $200,000 in the
current calendar year. (1)
_______ My spouse and I had a joint income in excess of $300,000
in each of the two most recent calendar years, and we reasonably
expect to have a joint income in excess of $300,000 in the
current calendar year. (1)
_______ I have an individual net worth, or my spouse and I have
a joint net worth, in excess of $1,000,000 exclusive of our
home. (2)
______________
(1)	To calculate ?income? for purposes herein, please use
adjusted gross income as reported on the relevant federal
tax return.
(2)	For purposes of this question, you may include your
spouse?s net worth, but you may not include the fair market
value of your personal residence

CORPORATIONS, PARTNERSHIPS, EMPLOYEE BENEFIT PLANS OR IRAs
Has the subscribing entity been formed for the specific purpose
of investing in the Equity?
Yes		No
If your answer to question 1 is ?No,? CHECK whichever of the
following statements (a-e) is applicable to the subscribing
entity.  If your answer to question 1 is ?Yes,? the subscribing
entity must be able to certify to statement (2) below in order
to qualify as an ?accredited investor.?
The undersigned entity certifies that it is an ?accredited
investor? because it is:
______ an employee benefit plan within the meaning of
Title 1 of the Employee Retirement Income
Security Act of 1974, provided that the
investment decision is made by a plan fiduciary,
as defined in section 3(21) of such Act, and the
plan fiduciary is a bank, savings and loan
association, insurance company, or registered
investment advisor; or
______ an employee benefit plan within the meaning of
Title 1 of the Employee Retirement Income
Security Act of 1974 that has total assets in
excess of $5,000,000; or
______ a corporation, partnership, or employee benefit
plan and each of its stockholders, partners, or
beneficiaries meet at least one of the conditions
described above under INDIVIDUAL ACCOUNTS.
Please also CHECK the appropriate space in that
section, and provide completed and signed
subscription agreements for each such individual;
or
______ a self-directed employee benefit plan and the
investment decision is made solely by a person
that meets at least one of the conditions
described above under INDIVIDUAL ACCOUNTS.
Please also CHECK the appropriate space in that
section, and provide a completed and signed
subscription agreement for such individual; or
______ a corporation, or similar business trust, or a
partnership that has total assets in excess of
$5,000,000.
If the answer to question 1 above is ?Yes,? please certify that
the statement below is true and correct:
_____	The undersigned entity certifies that it is
an accredited investor because each of its
stockholders, partners, members, or beneficiaries
meets at least one of the conditions described above
under INDIVIDUAL ACCOUNTS.  Please also CHECK the
appropriate space in that section and provide
completed and signed subscription agreements for each
such individual.
TRUST ACCOUNTS
Has the subscribing entity been formed for the specific purpose
of investing in the Equity?
Yes		No
If your answer to question 1 is ?No,? CHECK whichever of the
following statements (a-c) is applicable to the subscribing
entity.  If your answer to question 1 is ?Yes,? the subscribing
entity must be able to certify to the statement (c) below in
order to qualify as an ?accredited investor.?
The undersigned trustee certifies that the trust is an
?accredited investor? because:
______ the trust has total assets in excess of
$5,000,000 and the investment decision has been
made by a ?sophisticated person? (i.e., the
person whose investment experience is detailed in
Section IV below has such knowledge and
experience in financial and business matters that
he, she, or it is capable of evaluating the
merits and risks of an investment in the Equity);
or
______ the trustee making the investment decision on
its behalf is a bank (as defined in
Section 3(a)(2) of the Securities Act), a savings
and loan association or other institution (as
defined in Section 3(a)(5)(A) of the Securities
Act), acting in its fiduciary capacity; or
______ the grantor(s) of the trust may revoke the
trust at any time and regain title to the trust
assets and has (have) retained sole investment
control over the assets of the trust and the
(each) grantor(s) meets at least one of the
conditions described above under INDIVIDUAL
ACCOUNTS.  Please also CHECK the appropriate
space in that section and provide completed and
signed subscription agreements for each such
individual.
Verification of Accredited Investor Status.  Under recent rules
of the Securities and Exchange Commission, you are required to
provide us with documentation verifying your status as an
accredited investor.  A ?nonexclusive? list of possible
verifications you may provide to us include the following:

Verification based on income, such as copies of any Internal
Revenue Service form that reports income, such as Form W-2, Form
1099, Schedule K-1 of Form 1065, and a filed Form 1040;

Verification on net worth, including documentation dated within
the prior three months, such as bank statements, brokerage
statements, certificates of deposit, tax assessments and a
credit report from at least one of the nationwide consumer
reporting agencies;

A written confirmation from a registered broker-dealer, an SEC-
registered investment adviser, a licensed attorney, or a
certified public accountant stating that such person or entity
has taken reasonable steps to verify that you are an accredited
investor within the last three months and has determined that
you are an accredited investor.







Blank Space?
Name of Subscriber
________________________________________________________________
___________

Date of Birth / Date of Incorporation ________________________

Social Security Number / Tax ID
_____________________________________


Check 1 	Married _____ Single ______ Separated _______
Divorced________
Corporation _____ Trust ______ Partnership _______ Joint________

Home Address/ Business Address
________________________________________________________________
_____________

________________________________________________________________
_____________

________________________________________________________________
_____________

Phone Number __________________________________________

Email address____________________________________________






Signatures



      The Subscription Agreement contains various agreements,
certifications, and representations by Principal or investors
and should be carefully reviewed in their entirety before
executing this signature page.
      I certify that I have reviewed, and I am familiar with the
terms of the Subscription Agreement.  I agree to be bound by all
of the terms and conditions of this Subscription Agreement.

Dated:  _____________________________, 2020


Signature of Investor
________________________________________________________________

SUBSCRIPTION ACCEPTED
Decontaminate Inc, A Delaware Corporation


Signature of Company Executive


Date
1

Wells Fargo Building * 100 S Ashley Drive
Suite 600 * Tampa, Florida * 33602
decontaminate.ai * (727) 281-1996

PART II AND III

Subscription Agreement Decontaminate Inc
Unaccredited Investor

Please carefully read all instructions and the terms and
conditions of our Regulation A Offering Circular dated,
September 1, 2020, as filed with the Securities and Exchange
Commission (the ?SEC?). The Regulation A (as amended or the ?Reg
A?), was filed and is pending approval from the SEC. The
Subscription Agreement must be completed and signed before this
subscription for equity is considered.  Capitalized terms used
and not otherwise defined herein shall have the meanings set
forth in the Reg A Offering Circular.  If you need assistance,
please call your advisors or call us.

Minimum Investment
$1.00 per share of common stock
$20,000 or 20,000 shares

Your answers to the questions contained herein must be true and
correct in all respects, and a false representation by you may
constitute a violation of federal and state securities laws.
When the Subscription Agreement is complete, the company will
plan to pick up the check and subscription agreement or you may
use our account with Federal Express using account number 2522
70116 and send to:
Decontaminate Inc
100 S Ashley Drive Suite 600
Tampa, Florida 33602
(727) 281-1996







Covenants and Certifications
I certify that the information contained herein is true and
correct in all material respects and may be relied on by the
Company.
Under penalties of perjury, I certify that: (i) my taxpayer
identification number, address, email address, phone number and
date of birth shown in this Subscription Agreement is correct
and;
A.	Review of Information.  I have been furnished with and have
carefully read the Regulation A Offering Circular dated
September 1, 2020 ?Reg A? and the exhibits and any supplements
attached thereto prior to making a decision to invest in the
common stock equity of the company.
B.	Survival. I agree that the representations, certifications,
and agreements set forth in this Subscription Agreement shall
survive the purchase and delivery of the common stock (equity).
C.	Restricted Securities.  I understand that the investment in
the equity is an illiquid investment.  In particular, I
recognize that the investment has many clearly stated risks that
are listed in the Reg A and;
D.	Termination.  I agree that this subscription is and shall
be irrevocable, but my obligations hereunder will terminate if
this subscription is not accepted by the Company.
E.	Miscellaneous. I represent and warrant to the Company that:
I have carefully reviewed and understand the risks of, and other
considerations relating to, a purchase of equity;
I have been afforded the opportunity to obtain any information
necessary to verify the accuracy of any representations or
information set forth in the Reg A and have had all inquiries to
the Company answered, and have been furnished all requested
materials.
I have not been furnished any offering literature by the Company
or any of its affiliates, associates, or agents other than the
Reg A, and the documents referenced therein;
I am acquiring the equity for which I am subscribing for my own
account, as principal, for investment and not with a view to the
resale or distribution of all or any part of the Equity or
underlying securities;
All of the information which I have furnished to the Company or
which is set forth in the Subscription Agreement is correct and
complete as of the date of the Subscription Agreement.  If any
material change in this information should occur prior to my
subscription being accepted, I will immediately furnish the
revised or corrected information;
I further agree to be bound by all of the terms and conditions
described in the Reg A; and
I am the only person with a direct or indirect interest in the
equity subscribed for by the Subscription Agreement.
I am aware that no federal or state agency has reviewed or
passed upon the adequacy of the offering of equity, made any
finding or determination as to the fairness for investment, or
any recommendation or endorsement of the equity as an
investment.
I agree to indemnify and hold harmless the Company and its
officers, directors, employees, agents, and affiliates from and
against all damages, losses, costs, and expenses (including
reasonable attorneys? fees) that they may incur by reason of the
failure of the undersigned to fulfill any of the terms or
conditions of this Subscription Agreement, or by reason of any
breach of the representations and warranties made by the
undersigned herein, or in any document provided by the
undersigned to the Company.
This subscription agreement and the rights granted hereby are
not transferable or assignable by me without the written consent
of the Company.
If more than one person is executing this document, the
obligations of each shall be joint and several and the
representations and warranties contained in the Subscription
Agreement shall be deemed to be made by, and be binding upon,
each of these persons and his heirs, executors, administrators,
successors, and assigns.
This subscription, upon acceptance by the Company, shall be
binding upon my heirs, executors, administrators, successors,
and assigns.
The Subscription Agreement shall be construed in accordance with
and governed in all respects by the securities laws of the State
of Florida without giving effect to the principles of conflicts
of laws.
Any notices to be given hereunder may be given and shall be
effective as follows: to the Company at its principal place of
business located at 100 S Ashley Drive Suite 600, Tampa, FL
33602 and emailed to keith@decontaminate.ai; and to the
Investor, at their address and email address appearing in this
subscription agreement.  Notices by personal delivery shall be
effective upon such delivery that may be sent by a nationally-
recognized overnight courier, such notice to be effective at
time of delivery or attempted delivery upon production of proof
of same; and notices may also be sent by registered or certified
mail, return receipt requested, and shall be effective three
days after mailing, upon production of proof of receipt or of
attempted delivery.



BLANK SPACE


BY SIGNING, I ACKNOWLEDGE THAT I HAVE RECEIVED AND CAREFULLY
REVIEWED THE REG A OFFERING CIRCULAR DATED SEPTEMBER 1, 2020 AND
THAT I HEREBY AGREE TO BE BOUND BY THE TERMS OF THIS
SUBSCRIPTION AGREEMENT.

_______ I am a non-accredited investor. A non-accredited
investor is anyone making less than $200,000 annually (less than
$300,000 including a spouse) that also has a total net worth of
less than $1 million when their primary residence is excluded.

Name of Subscriber
________________________________________________________________
___________

Date of Birth ________________________

Social Security Number _____________________________________


Check 1 	Married _____ Single ______ Separated _______
Divorced________


Home Address
________________________________________________________________
_____________

________________________________________________________________
_____________

________________________________________________________________
_____________

Phone Number __________________________________________

Email address____________________________________________
Signatures



      The Subscription Agreement contains various agreements,
certifications, and representations by investors and should be
carefully reviewed in their entirety before executing this
signature page.
      I certify that I have reviewed, and I am familiar with the
terms of the Subscription Agreement.  I agree to be bound by all
of the terms and conditions of this Subscription Agreement.

Dated:  _____________________________, 2020


Signature of Investor
________________________________________________________________

SUBSCRIPTION ACCEPTED
Decontaminate Inc, A Delaware Corporation


Signature of Company Executive


Date
1

Wells Fargo Building * 100 S Ashley Drive
Suite 600 * Tampa, Florida * 33602
decontaminate.ai * (727) 281-1996